Arbutus Biopharma Corp - Common Shares, without par value (ABUS)
CUSIP: 03879J100
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Shares, without par value
- Shares outstanding
- 197,428,263
- Total 13F shares
- 96,687,257
- Share change
- +13,182,621
- Total reported value
- $298,333,597
- Put/Call ratio
- 11%
- Price per share
- $3.09
- Number of holders
- 129
- Value change
- +$40,873,896
- Number of buys
- 69
- Number of sells
- 39
Quarterly Holders Quick Answers
What is CUSIP 03879J100?
CUSIP 03879J100 identifies ABUS - Arbutus Biopharma Corp - Common Shares, without par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03879J100:
Top shareholders of ABUS - Arbutus Biopharma Corp - Common Shares, without par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Whitefort Capital Management, LP |
13F
|
Company |
6.5%
|
12,862,152
|
$33,184,352 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.3%
|
10,404,619
|
$26,843,917 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
4.5%
|
8,830,297
|
$22,782,167 | — | 31 Mar 2024 | |
| Two Seas Capital LP |
13F
|
Company |
4%
|
7,841,927
|
$20,232,172 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3%
|
5,987,907
|
$15,448,801 | — | 31 Mar 2024 | |
| Woodline Partners LP |
13F
|
Company |
2.1%
|
4,070,659
|
$10,502,300 | — | 31 Mar 2024 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
1.8%
|
3,520,382
|
$9,082,586 | — | 31 Mar 2024 | |
| FourWorld Capital Management LLC |
13F
|
Company |
1.5%
|
3,000,527
|
$7,741,360 | — | 31 Mar 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.5%
|
3,000,000
|
$7,740,000 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
2,958,887
|
$7,634,767 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
1.3%
|
2,611,890
|
$6,738,676 | — | 31 Mar 2024 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
1.1%
|
2,074,183
|
$5,351,392 | — | 31 Mar 2024 | |
| BlackBarn Capital Partners LP |
13F
|
Company |
1%
|
2,070,900
|
$5,342,922 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1%
|
1,995,804
|
$5,149,174 | — | 31 Mar 2024 | |
| Michael J. Sofia |
3/4/5
|
Chief Scientific Officer |
—
mixed-class rows
|
2,090,083
mixed-class rows
|
$3,820,904 | — | 01 Feb 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.69%
|
1,367,539
|
$3,528,251 | — | 31 Mar 2024 | |
| Centiva Capital, LP |
13F
|
Company |
0.69%
|
1,352,880
|
$3,490,430 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.54%
|
1,056,604
|
$2,726,038 | — | 31 Mar 2024 | |
| Corbin Capital Partners, L.P. |
13F
|
Company |
0.43%
|
853,304
|
$2,201,524 | — | 31 Mar 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.31%
|
612,277
|
$1,579,675 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.23%
|
451,305
|
$1,164,367 | — | 31 Mar 2024 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.22%
|
436,506
|
$1,126,185 | — | 31 Mar 2024 | |
| William H. Collier |
3/4/5
|
President and CEO, Director |
—
mixed-class rows
|
1,082,500
mixed-class rows
|
$1,101,985 | — | 01 Feb 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.21%
|
407,625
|
$1,051,673 | — | 31 Mar 2024 | |
| Saba Capital Management, L.P. |
13F
|
Company |
0.19%
|
373,460
|
$963,527 | — | 31 Mar 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.18%
|
349,435
|
$901,542 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.17%
|
339,215
|
$875,175 | — | 31 Mar 2024 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.17%
|
334,265
|
$872,431 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.15%
|
294,156
|
$758,922 | — | 31 Mar 2024 | |
| Ledgewood Wealth Advisors, LLC |
13F
|
Company |
0.14%
|
278,436
|
$718,365 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.12%
|
242,212
|
$624,907 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.11%
|
226,888
|
$585,371 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.09%
|
174,705
|
$450,739 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.09%
|
170,460
|
$439,779 | — | 31 Mar 2024 | |
| Elizabeth Howard |
3/4/5
|
EVP, GC, Compliance |
—
mixed-class rows
|
364,724
mixed-class rows
|
$437,862 | — | 01 Feb 2023 | |
| FMR LLC |
13F
|
Company |
0.08%
|
165,842
|
$427,872 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.07%
|
134,823
|
$347,844 | — | 31 Mar 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.06%
|
126,214
|
$325,632 | — | 31 Mar 2024 | |
| Clear Harbor Asset Management, LLC |
13F
|
Company |
0.06%
|
116,261
|
$299,953 | — | 31 Mar 2024 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.05%
|
102,924
|
$265,544 | — | 31 Mar 2024 | |
| Lighthouse Investment Partners, LLC |
13F
|
Company |
0.05%
|
99,055
|
$255,562 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.05%
|
97,916
|
$252,623 | — | 31 Mar 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.05%
|
96,040
|
$247,783 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.05%
|
89,186
|
$230,101 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.04%
|
88,132
|
$227,381 | — | 31 Mar 2024 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.04%
|
88,130
|
$227,000 | — | 31 Mar 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.04%
|
73,136
|
$188,000 | — | 31 Mar 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.04%
|
72,858
|
$187,973 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.03%
|
68,463
|
$176,634 | — | 31 Mar 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.03%
|
65,967
|
$170,195 | — | 31 Mar 2024 |
Institutional Holders of Arbutus Biopharma Corp - Common Shares, without par value (ABUS) as of Q2 2024
As of 30 Jun 2024,
Arbutus Biopharma Corp - Common Shares, without par value (ABUS) was held by
129 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
96,687,257 shares.
The largest 10 holders included
MORGAN STANLEY, Whitefort Capital Management, LP, BlackRock Inc., Two Seas Capital LP, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, ADAR1 Capital Management, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., FourWorld Capital Management LLC, and STATE STREET CORP.
This page lists
129
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
118
Q2 2024 holders
129
Holder diff
11
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.